EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer. (Q50912760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Zhijie Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Xuchao Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hua Bai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jun Zhao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Tongtong An

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jianchun Duan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Lu Yang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Meina Wu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Shuhang Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yuyan Wang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yilong Wu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jie Wang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

4 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

248-256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

12 February 2020

cites work

1 reference

ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer.

21 January 2018

1 reference

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

Pathobiology of ALK+ anaplastic large-cell lymphoma

21 January 2018

1 reference

Anaplastic Large Cell Lymphoma.

21 January 2018

1 reference

Inflammatory myofibroblastic tumours: where are we now?

21 January 2018

1 reference

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis

21 January 2018

1 reference

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

21 January 2018

1 reference

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

21 January 2018

1 reference

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

21 January 2018

1 reference

Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed

21 January 2018

1 reference

Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer

21 January 2018

1 reference

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

21 January 2018

1 reference

PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib

21 January 2018

1 reference

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

21 January 2018

1 reference

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

21 January 2018

1 reference

EML4-ALK fusion lung cancer: a rare acquired event

21 January 2018

1 reference

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

21 January 2018

1 reference

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation.

21 January 2018

1 reference

EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000341381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964709%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference